Rapid Growth in Telehealth for Cancer Care
Studies are starting to test how to transition telehealth from a temporary solution during the pandemic to a permanent part of cancer care.
Studies are starting to test how to transition telehealth from a temporary solution during the pandemic to a permanent part of cancer care.
Chronic stress may help cause the formation of structures called NETs that can help tumors metastasize, a new study in mice suggests.
NCI supports exceptional scientists from a variety of disciplines across the career continuum—from students just starting to explore a career path to well-established cancer investigators.…
Research Nurse Tricia Kunst shares what she loves most about her job and the people she gets to meet along the way.
FDA has approved lifileucel (Amtagvi), the first cancer treatment that uses immune cells called tumor-infiltrating lymphocytes, or TILs.
Overview The 12th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually May 6 – May 9, 2024 [8AM-12PM Eastern Time each day]. See…
Overview The 12th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually May 6 – May 9, 2024 [8AM-12PM Eastern Time each day]. See…
Emerging evidence suggests that the consequences of climate change may have an impact on the development of cancer and cancer care.
The NCI SBIR Innovation Lab podcast reaches and engages with entrepreneurs of all levels to share insights on commercialization and success stories from biotech industry…
The combination of Lonsurf and talazoparib (Talzenna) selectively killed cancer cells with mutations in the TP53 gene, researchers found in a study in mice.
Join fellow researchers, data scientists, and patient advocates in the quest to enhance today’s collection and exchange of standardized cancer data.